Adlyxin vs Saxenda

Adlyxin (lixisenatide) is a once-daily injection made by Sanofi for treating type 2 diabetes, while Saxenda (liraglutide) is a once-daily injection from Novo Nordisk approved for weight management in obesity. Both are given under the skin, but Adlyxin targets blood sugar control in diabetes, whereas Saxenda is used for chronic weight loss in people with obesity.

AI summary of the sources below.